Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
18.11
+0.53 (3.01%)
At close: Jul 21, 2025, 4:00 PM
18.30
+0.19 (1.05%)
Pre-market: Jul 22, 2025, 4:16 AM EDT
Omada Health Revenue
Omada Health had revenue of $54.96M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $189.67M. In the year 2024, Omada Health had annual revenue of $169.80M with 38.29% growth.
Revenue (ttm)
$189.67M
Revenue Growth
+38.29%
P/S Ratio
0.76
Revenue / Employee
$223,402
Employees
849
Market Cap
1.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 169.80M | 47.02M | 38.29% |
Dec 31, 2023 | 122.78M | 33.60M | 37.67% |
Dec 31, 2022 | 89.19M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOMDA News
- 3 days ago - Omada Health: Long Growth Runway Ahead - Seeking Alpha
- 4 days ago - Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - GlobeNewsWire
- 4 weeks ago - Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks - GlobeNewsWire
- 6 weeks ago - Omada Health: Helping Patients, Investors As Well? - Seeking Alpha
- 6 weeks ago - Omada Health IPO signals healthier market, avoids ‘down-round' trend - TechCrunch
- 6 weeks ago - Diabetes startup Omada Health finally went public after 14 years. Here's who made bank. - Business Insider
- 6 weeks ago - Digital health company Omada valued at $1.3 billion as shares jump in Nasdaq debut - Reuters
- 6 weeks ago - Omada shares open at $23 in Nasdaq debut after health-tech company's IPO - CNBC